新西兰带柄热解碳肩关节半肩置换十年登记数据
基于新西兰国家关节登记系统,2014年1月至2024年12月共记录277例患者288例带柄热解碳半肩置换(PyCHA),平均年龄55岁,平均随访50个月。使用量增长2.3倍,最常见指征为骨关节炎(53.5%);牛津肩关节评分(OSS)6个月均值为36.4,5年升至40.8,翻修率为每100组件年0.75例(95%CI 0.34至1.42)。
要点
- PyCHA在新西兰使用量10年间增长2.3倍,主要用于较年轻的骨关节炎患者。
- 6个月OSS均值36.4,5年升至40.8,翻修率每100组件年0.75例。
- 创伤后遗症组6个月OSS显著低于骨关节炎组(p=0.014)和股骨头坏死组(p=0.020)。
核心结论
- 带柄热解碳半肩置换在新西兰使用增加,中期临床结局良好且翻修率低,仍需进一步研究明确理想指征与长期结局。
研究设计与样本
- 回顾性登记研究,使用新西兰国家关节登记系统纳入2014年1月至2024年12月所有带柄PyCHA患者,评估手术指征、患者报告结局评分与翻修率。
- 共记录277例患者288例带柄PyCHA,平均年龄55岁(20至86岁),平均随访50个月(3至128个月)。
主要发现
- 研究期间PyCHA使用量增长2.3倍。
- 手术指征:骨关节炎154例(53.5%)、股骨头坏死52例(18.1%)、创伤后遗症48例(16.7%)、复发性脱位后38例(13.2%)。
- OSS均值术后6个月为36.4(SD 8.2),5年升至40.8(SD 7.9)。
- 翻修率为每100组件年0.75例(95%CI 0.34至1.42)。
- 创伤后遗症组6个月OSS均值显著低于骨关节炎组(p=0.014)和股骨头坏死组(p=0.020)。
关键数值与推荐
- 翻修率0.75/100组件年(95%CI 0.34至1.42)。
- 6个月OSS均值36.4(SD 8.2),5年40.8(SD 7.9)。
- 创伤后遗症组与骨关节炎组6个月OSS比较p=0.014,与股骨头坏死组比较p=0.020。
临床怎么用
- 对较年轻骨关节炎患者,带柄热解碳半肩置换可作为中期结局良好、翻修率低的选项。
- 创伤后遗症患者术后早期肩关节功能评分较低,术前咨询应予以说明。
- 理想指征与长期结局尚未确定,需持续随访并依托登记数据评估。
局限性
- 原文未报告该研究的局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Pyrocarbon has been used as a bearing surface in hemiarthroplasty (HA) of the shoulder for more than a decade. The use of pyrocarbon is thought to reduce the rate of glenoid erosion compared with metal HA, and reduce the risk of glenoid complications compared with anatomical total shoulder arthroplasty (aTSA). However, there is little information about the long-term outcomes. The aim of this study was to investigate the use of pyrocarbon HA (PyCHA) in New Zealand, and the clinical outcomes and revision rates. METHODS: The New Zealand National Joint Registry was used to obtain data on all patients undergoing HA of the shoulder with a stemmed PyCHA. Data which were assessed included the indication for surgery, patient-reported outcome scores, and revision rates. RESULTS: Between January 2014 and December 2024, 288 stemmed PyCHAs were recorded in 277 patients, with a mean age of 55 years (20 to 86). The mean follow-up was 50 months (3 to 128). The use increased 2.3-fold during the study period. The most common indication for surgery was osteoarthritis (OA) (154 (53.5%)), followed by avascular necrosis (AVN) (52 (18.1%)), the sequelae of trauma (48 (16.7%)) and after recurrent dislocation (38 (13.2%)). The mean Oxford Shoulder Score (OSS) was 36.4 (SD 8.2) six months postoperatively, increasing to 40.8 (SD 7.9) at five years. The revision rate was 0.75 per 100 component-years (95% CI 0.34 to 1.42). The mean six-month OSS was significantly lower in the sequelae of trauma group than in the OA (p = 0.014) or AVN groups (p = 0.020). CONCLUSION: The use of PyCHA is increasing in New Zealand. It is typically used in younger patients with OA. It has good clinical outcomes and low revision rates at mid-term follow-up. Further study is needed to assess the ideal indications for this procedure and the long-term clinical outcomes and revision rates.
引用
- Konarski AJ, Mohammed KD. The experience of stemmed pyrocarbon shoulder hemiarthroplasty in New Zealand : ten years of registry data. Bone Joint J. 2026. PMID: 42219169. doi:10.1302/0301-620X.108B6.BJJ-2025-1190.R2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。